vTv Therapeutics Inc.VTVTNASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-43.86%
↓ 76% below average
Average (39q)
-24.89%
Historical baseline
Range
High:173.45%
Low:-548.67%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -43.86% |
| Q2 2025 | -18.74% |
| Q1 2025 | -40.12% |
| Q4 2024 | 24.02% |
| Q3 2024 | 7.66% |
| Q2 2024 | -6.47% |
| Q1 2024 | -39.88% |
| Q4 2023 | 47.73% |
| Q3 2023 | -18.42% |
| Q2 2023 | -24.89% |
| Q1 2023 | 5.18% |
| Q4 2022 | -11.36% |
| Q3 2022 | -35.23% |
| Q2 2022 | 55.03% |
| Q1 2022 | 0.62% |
| Q4 2021 | -548.67% |
| Q3 2021 | -78.78% |
| Q2 2021 | 85.66% |
| Q1 2021 | -476.64% |
| Q4 2020 | 173.45% |
| Q3 2020 | 54.48% |
| Q2 2020 | 28.70% |
| Q1 2020 | -7.39% |
| Q4 2019 | -21.92% |
| Q3 2019 | -25.19% |
| Q2 2019 | -33.74% |
| Q1 2019 | -97.53% |
| Q4 2018 | -37.06% |
| Q3 2018 | 74.09% |
| Q2 2018 | -4.07% |
| Q1 2018 | 31.52% |
| Q4 2017 | -18.11% |
| Q3 2017 | 7.90% |
| Q2 2017 | 6.09% |
| Q1 2017 | -4.20% |
| Q4 2016 | -1.43% |
| Q3 2016 | 10.41% |
| Q2 2016 | -15.71% |
| Q1 2016 | -21.55% |
| Q4 2015 | 22.76% |